Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Huang, Lei  [Clear All Filters]
2023
Huang L, Lyu Z, Yang H, Gu M, Jiao Y, Shi Y. Acute toxicities of intravenous, intraperitoneal, or intratumoral injection of natural killer cells in human pancreatic adenocarcinoma-bearing mice: Randomized study. Int Immunopharmacol. 2023;124(Pt A):110881.
Yi F, Xiao H, Song M, Huang L, Huang Q, Deng J, Yang H, Zheng L, Wang H, Gu W. BMSC-derived exosomal miR-148b-3p attenuates OGD/R-induced HMC3 cell activation by targeting DLL4 and Notch1. Neurosci Res. 2023.
Li T-T, Zhang B, Fang H, Shi M, Yao W-Q, Li Y, Zhang C, Song J, Huang L, Xu Z, et al. Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial. EBioMedicine. 2023;92:104600.
Zhu X, Huang Q, Huang L, Luo J, Li Q, Kong D, Deng B, Gu Y, Wang X, Li C, et al. MAE-seq refines regulatory elements across the genome. Nucleic Acids Res. 2023.
Huang L, Lu S, Bian M, Wang J, Yu J, Ge J, Zhang J, Xu Q. Punicalagin attenuates TNF-α-induced oxidative damage and promotes osteogenic differentiation of bone mesenchymal stem cells by activating the Nrf2/HO-1 pathway. Exp Cell Res. 2023:113717.
Sun Z, Cai Y, Chen Y, Jin Q, Zhang Z, Zhang L, Li Y, Huang L, Wang J, Yang Y, et al. Ultrasound-targeted microbubble destruction promotes PDGF-primed bone mesenchymal stem cell transplantation for myocardial protection in acute Myocardial Infarction in rats. J Nanobiotechnology. 2023;21(1):481.